Document Detail


Neurodevelopmental outcome after COX inhibitor treatment for patent ductus arteriosus.
MedLine Citation:
PMID:  20153127     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIM: To compare neurodevelopmental results in very low birth weight (VLBW) infants two years after successful or failed cyclooxygenase inhibitor treatment with either indomethacin or ibuprofen for a haemodynamically significant patent ductus arteriosus (hsPDA). METHODS: We retrospectively evaluated closure rates and outcome parameters of VLBW infants with hsPDA 89 of whom were treated with indomethacin and 93 with ibuprofen. RESULTS: Indomethacin and ibuprofen therapy groups did not differ in their baseline clinical profile (median gestational age 26.0 and 26.2wksd) in early (median CRIB 6 and 5, respiratory distress >2 degrees in 36 and 34 infants) and late morbidities (intraventricular hemorrhage >2 degrees in 9 and 10 infants, bronchopulmonary dysplasia in 31 and 27 infants, 80 and 85 survivors), PDA closure rates (63 and 58%) or neurodevelopmental outcome. The therapy failure group (54 infants) was characterized by lower median gestational age (25.0wksd) and higher mortality (17%). No differences were found in the neurodevelopmental outcome of the surviving infants with ligation as compared to the survivors with successful pharmacological closure of the PDA at 24months corrected age. CONCLUSION: Use of either ibuprofen or indomethacin for closure of a hsPDA did not influence two year neurodevelopmental outcomes in VLBW infants.
Authors:
C Rheinlaender; D Helfenstein; C Pees; E Walch; C Czernik; M Obladen; P Koehne
Related Documents :
20336077 - Patent ductus arteriosus hemodynamics in very premature infants treated with poractant ...
18046337 - Fluid regimens in the first week of life may increase risk of patent ductus arteriosus ...
737247 - Pulmonary and circulatory function in preterm lambs treated with hydrocortisone in utero.
900167 - Prolonged rupture of fetal membranes and decreased frequency of respiratory distress sy...
4014067 - Relationship between birth weight and subsequent weight gain.
19788827 - Role of rhinovirus c in apparently life-threatening events in infants, spain.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-02-12
Journal Detail:
Title:  Early human development     Volume:  86     ISSN:  1872-6232     ISO Abbreviation:  Early Hum. Dev.     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-03-09     Completed Date:  2010-06-10     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7708381     Medline TA:  Early Hum Dev     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  87-92     Citation Subset:  IM    
Affiliation:
Department of Neonatology, Charit?, Universit?tsmedizin Berlin, Campus Virchow-Klinikum, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Central Nervous System / drug effects*,  growth & development
Child Development / drug effects,  physiology
Child, Preschool
Cyclooxygenase Inhibitors / therapeutic use*
Ductus Arteriosus, Patent / drug therapy*
Female
Gestational Age
Humans
Ibuprofen / therapeutic use*
Indomethacin / therapeutic use*
Infant
Infant, Newborn
Infant, Premature
Infant, Very Low Birth Weight
Male
Psychomotor Performance / drug effects,  physiology
Retrospective Studies
Chemical
Reg. No./Substance:
0/Cyclooxygenase Inhibitors; 15687-27-1/Ibuprofen; 53-86-1/Indomethacin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Perinatal nutrient restriction reduces nephron endowment increasing renal morbidity in adulthood: a ...
Next Document:  Different pre-term formulas for different pre-term infants.